Rhumbline Advisers Raises Stock Position in Cardiff Oncology, Inc. (NASDAQ:CRDF)
Rhumbline Advisers boosted its position in shares of Cardiff Oncology, Inc. (NASDAQ:CRDF – Free Report) by 18.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 63,142 shares of the company’s stock after buying an additional 9,970 shares during the quarter. Rhumbline Advisers’ holdings in […]
Rhumbline Advisers boosted its position in shares of Cardiff Oncology, Inc. (NASDAQ:CRDF – Free Report) by 18.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 63,142 shares of the company’s stock after buying an additional 9,970 shares during the quarter. Rhumbline Advisers’ holdings in […]
